Back to Search Start Over

Transcriptomic and proteomic pathways of diabetic and non-diabetic mitochondrial transplantation.

Authors :
Doulamis IP
Nomoto RS
Tzani A
Hong X
Duignan T
Celik A
Del Nido PJ
McCully JD
Source :
Scientific reports [Sci Rep] 2022 Dec 21; Vol. 12 (1), pp. 22101. Date of Electronic Publication: 2022 Dec 21.
Publication Year :
2022

Abstract

Reduced mitochondrial function increases myocardial susceptibility to ischemia-reperfusion injury (IRI) in diabetic hearts. Mitochondrial transplantation (MT) ameliorates IRI, however, the cardioprotective effects of MT may be limited using diabetic mitochondria. Zucker Diabetic Fatty (ZDF) rats were subjected to temporary myocardial RI and then received either vehicle alone or vehicle containing mitochondria isolated from either diabetic ZDF or non-diabetic Zucker lean (ZL) rats. The ZDF rats were allowed to recover for 2 h or 28 days. MT using either ZDF- or ZL-mitochondria provided sustained reduction in infarct size and was associated with overlapping upregulation of pathways associated with muscle contraction, development, organization, and anti-apoptosis. MT using either ZDF- or ZL-mitochondria also significantly preserved myocardial function, however, ZL- mitochondria provided a more robust long-term preservation of myocardial function through the mitochondria dependent upregulation of pathways for cardiac and muscle metabolism and development. MT using either diabetic or non-diabetic mitochondria decreased infarct size and preserved functional recovery, however, the cardioprotection afforded by MT was attenuated in hearts receiving diabetic compared to non-diabetic MT.<br /> (© 2022. The Author(s).)

Details

Language :
English
ISSN :
2045-2322
Volume :
12
Issue :
1
Database :
MEDLINE
Journal :
Scientific reports
Publication Type :
Academic Journal
Accession number :
36543810
Full Text :
https://doi.org/10.1038/s41598-022-25858-z